- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05719948
Combined Continuous and Pulsed Radiofrequency Ablation for Pain Relief and Their Safety in Cervical Facet Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Diagnostic procedure symptomatic facet joint was designated according to pain referral. Also, medial branches were injected with 2% lidocaine 0.3 ml per site.
Treatment procedure The posterior technique was first described in 1995 . All interventions assessed the intravenous saline lock on arrival at the outpatient department using pulse oximetry and noninvasive blood pressure monitoring and intravenous sedation as required. Patients were assigned in a prone position under C-ARM fluoroscopic guidance with a Neurotherm NT 2000 Lesion Generator the (USA manufactured) . The electrode pad of the radiofrequency equipment was attached to the ipsilateral side of the posterior thigh. After the skin was then anesthetized with 1% lidocaine, a 20-gauge, 10-cm cannula with 10-mm curved active tip (Diros RF Cannula, Diros Technology Inc., Canada) was inserted along a 15 to 30 degree angle to the sagittal plane (slightly posterior oblique approach) . The cannula was applied until reaching the lateral part of the articular pillar . Then the depth of the cannula was checked using a lateral view. A probe was inserted through the cannula and linked to a radiofrequency generator (Diros Technology OWL, Canada). After impedance were accomplished at below 500 Ohm, sensory stimulation was performed at 50 Hz and the patient reported not feeling any tingling sensation along the distribution of dermatome. Consequently, a motor stimulation (2 Hz) was executed until multifidus twitching was presented at stimulation less than 1 volts and no motor twitching was observed along the myotome. A non-ionic contrast medium was injected to ensure the intravascular injection before 1% lidocaine 0.5 ml was injected after the needle reached the desired location. The study investigated two lesions due to the anatomical variation of the medial branches. Patients in the CRF group (n = 16) underwent CRF at 80°C for 90 seconds for 2 cycles. Patients in the CPRF group underwent CRF at 80°C for 90 seconds for 1 cycle followed by PRF at 42°C for 120 seconds for 1 cycle. 0.125% bupivacaine plus 2 mg of dexamethasone in a total volume of 1 mL were injected after lesioning had performed.
Measurement The demographic data including age, sex, comorbidities, body mass index (BMI), level of procedure, visual analog scale (VAS;1-100) Neck Pain Disability Index and complications were reviewed. It contains ten sectors: seven sectors related to everyday existing behaviors, two sectors correlated to pain, and one sector correlated to concentration. All items are marked from 0 to 5. A mark of 0 denotes the maximum level of function, while a mark of 5 indicates the bottom level of function. The maximum mark is 50, and a greater mark relates to an increased level of disability. The NDI scores were recorded before intervention and first month, third month, sixth month, ninth months and 12 months after intervention. The follow-up was performed either face to face or by phone, and patients were not permitted to use over-the counter analgesic medication. The primary outcome was number of patients who had successful treatment, expressed as at least 80% pain relief from baseline and NDI score less than 15 for at least 3 months . The secondary outcomes comprised the duration of pain relief defined as the time of pain relief until VAS had restored to at least 50% from baseline and side effects including numbness, ataxia, dysesthesia, hypersensitivity, itching and muscular weakness (dropped head syndrome) between group comparisons. A research assistant, who was uninvolved in the intervention or post-operative follow-up, collected all data in prospective medical records.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Fayoum, Egypt, 63512
- Atef Mohamed mahmoud
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients age from (30-75) years old.
- ASA ( I, II).
- Patients presenting positive diagnostic cervical medial branche block defined as pain relief more than 50% from baseline.
Exclusion Criteria:
- Repeated cervical radiofrequency ablation.
- Patients presenting neck pain with radicular symptoms.
- Previous cervical discectomy or fixation surgery.
- Malignancy.
- local infection
- Psychological problem.
- language barrier.
- History of allergy to radio-opaque contrast solution,lidocaine or bupivacaine. - Inadequate medical proplem (hepatic, renal, cardiac) patients.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Flouroscopic guidance cervical medial branch continous RF ablation
After the patient lying prone we obtaining the posterior approach with PA view then lateral 15 degrees the C shaped edge of the cervical vertebrae were appeared and then we advance the needle till reaching this C shaped till hitting the bone then slipping the active tip slightly therafter we obtaining lateral view to determine the depth of the needle over the cervical pedicle. patients in the continous radiofrequency group will be underwent continous radiofrequency at 80°C for 90 seconds for 2 cycles |
Electromagnetic wave deposition near nerve tissue for pain management
|
|
Active Comparator: Flouroscopic guidance cervical medial branch combined pulsed and continous RF ablation
After the patient lying prone we obtaining the posterior approach with PA view then lateral 15 degrees the C shaped edge of the cervical vertebrae were appeared and then we advance the needle till reaching this C shaped till hitting the bone then slipping the active tip slightly therafter we obtaining lateral view to determine the depth of the needle over the cervical pedicle. patients in the continous and pulsed group will be underwent continous and pulsed radiofrequency at 80°C for 90 seconds for 1 cycle followed by pulsed radiofrequency at 42°C for 120 seconds for 1 cycle |
Electromagnetic wave deposition near nerve tissue for pain management
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
neck disability index pre and post-intervention between comparison groups
Time Frame: One month
|
Neck disability index : It contains ten sectors: seven sectors related to everyday existing behaviors, two sectors correlated to pain, and one sector correlated to concentration.
All items are marked from 0 to 5. A mark of 0 denotes the maximum level of function, while a mark of 5 indicates the bottom level of function.
The maximum mark is 50, and a greater mark relates to an increased level of disability.
|
One month
|
|
neck disability index pre and post-intervention between comparison groups
Time Frame: 3 months
|
Neck disability index : It contains ten sectors: seven sectors related to everyday existing behaviors, two sectors correlated to pain, and one sector correlated to concentration.
All items are marked from 0 to 5. A mark of 0 denotes the maximum level of function, while a mark of 5 indicates the bottom level of function.
The maximum mark is 50, and a greater mark relates to an increased level of disability.
|
3 months
|
|
neck disability index pre and post-intervention between comparison groups
Time Frame: 6 months
|
Neck disability index : It contains ten sectors: seven sectors related to everyday existing behaviors, two sectors correlated to pain, and one sector correlated to concentration.
All items are marked from 0 to 5. A mark of 0 denotes the maximum level of function, while a mark of 5 indicates the bottom level of function.
The maximum mark is 50, and a greater mark relates to an increased level of disability.
|
6 months
|
|
neck disability index pre and post-intervention between comparison groups
Time Frame: 12 months
|
Neck disability index : It contains ten sectors: seven sectors related to everyday existing behaviors, two sectors correlated to pain, and one sector correlated to concentration.
All items are marked from 0 to 5. A mark of 0 denotes the maximum level of function, while a mark of 5 indicates the bottom level of function.
The maximum mark is 50, and a greater mark relates to an increased level of disability.
|
12 months
|
|
VAS SCORE
Time Frame: One month
|
of procedure, visual analog scale (VAS;1-100)
|
One month
|
|
VAS SCORE
Time Frame: 3 months
|
of procedure, visual analog scale (VAS;1-100)
|
3 months
|
|
VAS SCORE
Time Frame: 6 months
|
of procedure, visual analog scale (VAS;1-100)
|
6 months
|
|
VAS SCORE
Time Frame: 12 months
|
of procedure, visual analog scale (VAS;1-100)
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of pain relief
Time Frame: One month, 3months,6 months, 12 months
|
The duration of pain relief was expressed as the period between pain relief and pain reoccurrence to 50% of pre-procedural pain level
|
One month, 3months,6 months, 12 months
|
|
Complications
Time Frame: One month, 3 months, 6months, 12 months
|
Numbness, dysethesia, drop head syndrome, hypersensitivity, ataxia
|
One month, 3 months, 6months, 12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R 333
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radiofrequency Ablation
-
National Taiwan University HospitalRecruitingRadiofrequency AblationTaiwan
-
Izmir City HospitalActive, not recruitingRadiofrequency Catheter AblationTurkey (Türkiye)
-
Sakarya UniversityNot yet recruitingRadiofrequency Ablation | Knee Osteoarthristis | NEUROLYSIS
-
Mayo ClinicCompletedRadiofrequency Ablation in Patients With Spinal HardwareUnited States
-
Tanta UniversityCompletedRadiofrequency Ablation | PET/CT | Hepatocellular MalignancyEgypt
-
Capital Medical UniversityUnknown
-
Chengdu University of Traditional Chinese MedicineNot yet recruitingRadiofrequency Ablation | Anticoagulant Drugs | Oral Antiplatele | Lower Extremity Varicose Veins
-
Second Affiliated Hospital, School of Medicine,...RecruitingImmunosuppression | Radiofrequency Ablation | Tumor ImmunityChina
-
Wroclaw Medical UniversityRecruitingAtrial Fibrillation (AF) | Radiofrequency Catheter Ablation | Ablation Techniques | Pulsed Field AblationPoland
-
Zonguldak Bulent Ecevit UniversityCompletedVaricose Veins | Regional Anaesthesia | Radiofrequency Ablation | Suprainguinal Fascia Iliaca BlockTurkey (Türkiye)
Clinical Trials on Flouroscopic guidance cervical medial branch radiofrequency ablation
-
Europainclinics z.ú.Brno University Hospital; Pavol Jozef Safarik University; Slovak Academy of SciencesUnknown
-
Diskapi Teaching and Research HospitalCompletedBack Pain | Sacroiliac Joint ArthritisTurkey
-
Europainclinics z.ú.Slovak Academy of SciencesActive, not recruiting
-
Milton S. Hershey Medical CenterNot yet recruitingLumbar SpondylosisUnited States
-
Centre hospitalier de l'Université de Montréal...CompletedNeck Pain | Facet Joint Pain | Radiofrequency AblationCanada
-
Montefiore Medical CenterPacira Pharmaceuticals, IncRecruiting
-
University of UtahActive, not recruitingCervical Pain | Cervical Facet Joint PainUnited States
-
Montreal General HospitalUniversity of British ColumbiaRecruiting
-
University Health Network, TorontoRecruitingNeck Pain | Zygapophyseal Joint ArthritisCanada, Spain
-
Seoul National University Bundang HospitalUnknownLow Back Pain | Arthropathy | Lumbar Facet Joint PainKorea, Republic of